Editorial Comment on "Outcomes and Safety Profile of Repeated Progressive Site-Directed Therapy for Patients With Oligometastatic Castration-Resistant Prostate Cancer".

Aizawa R; Mizowaki T

doi:10.1111/iju.70272

← 뒤로

Editorial Comment on "Outcomes and Safety Profile of Repeated Progressive Site-Directed Therapy for Patients With Oligometastatic Castration-Resistant Prostate Cancer".

사설/논평 0/5 보강

International journal of urology : official journal of the Japanese Urological Association 📖 저널 OA 36.8% 2021~2026 2026 Vol.33(1) p. e70272 OA

Aizawa R, Mizowaki T

📖 무료 전문 🔓 OA PDF unpaywall · unknown

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Aizawa R, Mizowaki T (2026). Editorial Comment on "Outcomes and Safety Profile of Repeated Progressive Site-Directed Therapy for Patients With Oligometastatic Castration-Resistant Prostate Cancer".. International journal of urology : official journal of the Japanese Urological Association, 33(1), e70272. https://doi.org/10.1111/iju.70272

MLA Aizawa R, et al.. "Editorial Comment on "Outcomes and Safety Profile of Repeated Progressive Site-Directed Therapy for Patients With Oligometastatic Castration-Resistant Prostate Cancer".." International journal of urology : official journal of the Japanese Urological Association, vol. 33, no. 1, 2026, pp. e70272.

PMID 41159547 ↗

DOI 10.1111/iju.70272

같은 제1저자의 인용 많은 논문 (2)

Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI.
Anticancer research 2025
Narrative review of focal boost to intraprostatic dominant lesion in intensity-modulated radiation therapy for localized or locally advanced prostate cancer.
International journal of clinical oncology 2025